Eye test could replace invasive heart procedure for millions
NCT ID NCT06692751
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a simple, non-invasive eye scan (OCT-A) can diagnose microvascular angina, a heart condition affecting about 112 million people worldwide. Currently, diagnosis requires an invasive heart procedure to measure microcirculatory resistance. Researchers will compare eye scan results with the standard invasive test in 158 adults to see if the eye scan is a reliable alternative. If proven effective, this could make diagnosis faster, cheaper, and more accessible.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a quick, non-invasive eye scan to diagnose microvascular angina, replacing the current invasive heart procedure.
What could go wrong
This is an early observational study, not a treatment trial. It only tests if the eye scan matches the invasive test results, and may not prove useful for all patients or replace the gold standard.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROVASCULAR ANGINA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••